EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C26H54NO7P |
| Net Charge | 0 |
| Average Mass | 523.692 |
| Monoisotopic Mass | 523.36379 |
| SMILES | CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(C)=O |
| InChI | InChI=1S/C26H54NO7P/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-21-31-23-26(34-25(2)28)24-33-35(29,30)32-22-20-27(3,4)5/h26H,6-24H2,1-5H3/t26-/m1/s1 |
| InChIKey | HVAUUPRFYPCOCA-AREMUKBSSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Role: | beta-adrenergic antagonist An agent that binds to but does not activate β-adrenergic receptors thereby blocking the actions of endogenous or exogenous β-adrenergic agonists. β-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety. |
| Applications: | bronchoconstrictor agent A drug which causes a narrowing of the lumen of a bronchus or bronchiole. vasodilator agent A drug used to cause dilation of the blood vessels. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. hematologic agent Drug that acts on blood and blood-forming organs and those that affect the hemostatic system. beta-adrenergic antagonist An agent that binds to but does not activate β-adrenergic receptors thereby blocking the actions of endogenous or exogenous β-adrenergic agonists. β-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (CHEBI:44811) has role antihypertensive agent (CHEBI:35674) |
| 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (CHEBI:44811) has role bronchoconstrictor agent (CHEBI:50141) |
| 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (CHEBI:44811) has role hematologic agent (CHEBI:50248) |
| 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (CHEBI:44811) has role vasodilator agent (CHEBI:35620) |
| 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (CHEBI:44811) has role β-adrenergic antagonist (CHEBI:35530) |
| 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (CHEBI:44811) is a 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine (CHEBI:36707) |
| IUPAC Name |
|---|
| (2R)-2-acetoxy-3-(hexadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate |
| Synonyms | Source |
|---|---|
| 1-O-hexadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine | ChemIDplus |
| 1-O-hexadecyl-2-O-acetyl-sn-glycero-3-phosophocholine | ChemIDplus |
| 1-O-hexadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine | ChemIDplus |
| 1-O-hexadecyl PAF | ChEBI |
| 1-O-hexadecyl-platelet-activating factor | ChemIDplus |
| 1-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine | LIPID MAPS |
| UniProt Name | Source |
|---|---|
| 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine | UniProt |
| Manual Xrefs | Databases |
|---|---|
| DB02261 | DrugBank |
| LMGP01020046 | LIPID MAPS |
| PFS | PDBeChem |
| Platelet-activating_factor | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| Reaxys:3574588 | Reaxys |
| CAS:74389-68-7 | ChemIDplus |
| Citations |
|---|